These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 163093)

  • 1. Adenosine 3',5'-monophosphate phosphodiesterase activity in experimental animal tumours which are either sensitive or resistant to bifunctional alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jan; 24(2):205-10. PubMed ID: 163093
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterisation of cyclic adenosine 3':5'-monophosphate phospodiesterase from Walker carcinoma sensitive and resistant to bifunctional alkylating agents.
    Tisdale MJ
    Biochim Biophys Acta; 1975 Jul; 397(1):134-43. PubMed ID: 238630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in adenosine 3', 5'-monophosphate-binding protein in Walker carcinoma cells sensitive or resistant to alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Aug; 25(16):1831-6. PubMed ID: 9089
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of cyclic 3',5'-nucleotide phosphodiesterase-a possible mechanism of action of bifunctional alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jan; 24(2):211-7. PubMed ID: 163094
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of alkylating agents on the activity of adenosine 3',5'-monophosphate-dependent protein kinase in Walker carcinoma cells.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Nov; 25(21):2365-70. PubMed ID: 187201
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quantitative evaluation of the efficacy of antineoplastic agents].
    Karavainova MKh
    Farmakol Toksikol; 1971; 34(5):618-21. PubMed ID: 5004886
    [No Abstract]   [Full Text] [Related]  

  • 7. The reaction of alkylating agents with cyclic 3',5'-nucleotide phosphodiesterase.
    Tisdale MJ
    Chem Biol Interact; 1974 Aug; 9(2):145-53. PubMed ID: 4371511
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative antitumor effects of peptichemio and other alkylating agents.
    Schmid FA; Banks SE; Stock CC
    Cancer Treat Rep; 1977; 61(3):473-5. PubMed ID: 872145
    [No Abstract]   [Full Text] [Related]  

  • 9. The cure and concomitant immunization of mice bearing Ehrlich ascites tumors by treatment with an antibody--alkylating agent complex.
    Flechner I
    Eur J Cancer (1965); 1973 Oct; 9(10):741-5. PubMed ID: 4803217
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclic adenosine 3',5'-monophosphate phosphodiesterase activity in normal, differentiating, regenerating, and neoplastic liver.
    Clark JF; Morris HP; Weber G
    Cancer Res; 1973 Feb; 33(2):356-61. PubMed ID: 4347469
    [No Abstract]   [Full Text] [Related]  

  • 11. Guanosine 3',5'-monophosphate and the action of alkylating agents.
    Tisdale MJ; Phillips BJ
    Chem Biol Interact; 1977 Dec; 19(3):375-81. PubMed ID: 202413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of action of the tumour inhibitory triazenes.
    Audette RC; Connors TA; Mandel HG; Merai K; Ross WC
    Biochem Pharmacol; 1973 Aug; 22(15):1855-64. PubMed ID: 4722457
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effects of alkylating agents and other anti-tumour agents on the intracellular level of adenosine 3',5'-monophosphate in Walker carcinoma.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jul; 24(13-14):1271-6. PubMed ID: 167787
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclic 3',5'-nucleotide monophosphate phosphodiesterase activity in hepatomas of different growth rates.
    Rhoads AR; Morris HP; West WL
    Cancer Res; 1972 Dec; 32(12):2651-5. PubMed ID: 4345399
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo inhibition of tumor growth by cyclic adenosine 3',5'-monophosphate derivatives.
    Cho-Chung YS
    Cancer Res; 1974 Dec; 34(12):3492-6. PubMed ID: 4371966
    [No Abstract]   [Full Text] [Related]  

  • 16. Transplantable mouse plasma cell tumors in experimental chemotherapy.
    Teller MN; Abraham D; Bowie M; Carbone PP
    J Natl Cancer Inst; 1969 Jul; 43(1):123-31. PubMed ID: 5816022
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of alkylating agents on adenosine 3',5'-monophosphate metabolism in Walker carcinoma.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Aug; 25(15):1793-7. PubMed ID: 182174
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of chemical agents against the plasma cell tumor LPC-1 in mice.
    Abraham D; Carbone PP; Venditti JM; Kline I; Goldin A
    Biochem Pharmacol; 1967 Apr; 16(4):665-73. PubMed ID: 6033787
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclic nucleotide metabolism in Walker carcinoma cells resistant to alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1978 Mar; 27(6):947-52. PubMed ID: 207283
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth inhibitory and haematological effects of alkylating agents and attempts at their modification to give greater selectivity of anti-tumour action.
    Elson LA
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):51-9. PubMed ID: 5659736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.